Skip to main content
. 2019 Feb 15;20(4):840. doi: 10.3390/ijms20040840

Figure 3.

Figure 3

A single nanomaterial (e.g., nanoparticles) can be functionalized with different moieties to target different cell populations in the TME (tumor and stromal cells), enabling a combined strategy for cancer therapeutics. CAFs, Cancer-associated fibroblasts; FRβ, folate-receptor beta; PI-88, Phosphomanno-pentose sulfate.